Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Medinova Diagnostic Services Ltd Performance

Today's Low
36.54
arrowIcon
Today's High
40.30
52 Wk Low
21.90
arrowIcon
52 Wk High
64.50


Open

40.3

Traded Value (Cr)

1.10 L

Prev. Close

38.39

VWAP

37.39

Volume

2,898

Face Value

10

Medinova Diagnostic Services Ltd Fundamentals

Market Cap
₹ 38 Cr
P/E Ratio (TTM)
19.13
P/B Ratio
0.00
Debt to Equity
-1.60
ROE
-63.97 %
EPS (TTM)
2.00
Dividend Yield
0.00%
Book Value
-3.10

Click here to know more about Fundamentals

Medinova Diagnostic Services Ltd Financials

Medinova Diagnostic Services Ltd Financials

Medinova Diagnostic Services Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 62.14 % 62.14 % 62.14 % 62.14 %
Retail 35.58 % 35.49 % 36.02 % 36.00 %
Others 2.28 % 2.38 % 1.84 % 1.86 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

62.14%

Retail

35.58%

Others

2.28%

FII

0.00%

Mutual Funds

0.00%

Promoters

62.14%

Retail

35.49%

Others

2.38%

FII

0.00%

Mutual Funds

0.00%

Promoters

62.14%

Retail

36.02%

Others

1.84%

FII

0.00%

Mutual Funds

0.00%

Promoters

62.14%

Retail

36.00%

Others

1.86%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹39.64

PIVOT

resistance-arrow
Resistance
First Resistance₹40.937
Second Resistance₹42.293
Third Resistance₹43.587
support-arrow
Support
First Resistance₹38.287
Second Resistance₹36.993
Third Resistance₹35.637
RSI58.913
MACD3.515
ADX37.553
CCI22.998

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day4,1743,81291.33
Week4,9214,46892.55
1 Month5,7295,40296.09
6 Months000.00

About Medinova Diagnostic Services Ltd

Medinova Diagnostic Services Ltd (MDSL), incorporated in Mar.'93, commenced business on 26 Mar.'93. It belongs to Standard Organics group. The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology. MDSL has acquired the business and undertaking of the diagnostic services division of Standard Medical & Pharmaceuticals (SMPL) as a going concern together with assets and liabilities from 1 Apr.'93. It has four main diagnostic centres in Hyderabad, Bangalore, Pune, and Kolkata apart from mini/medium-sized franchise centres at Karimnagar, Mancherial, Vizag, Nellore. MDSL came out with a public issue of 67.50 lac equity shares at par, aggregating Rs 6.75 cr, in Nov.'93. The company has installed three magnetic resonance imaging units and other equipment with the latest technology in diagnostic centres in Hyderabad and Bangalore, at a capital outlay of Rs 10 cr. MDSL has completed a consultancy assignment for an overseas project in Abuja, Nigeria, earning valuable foreign exchange. A new CT machine was installed in Hyderabad in Feb.'95. In the year 1996-97 the company Medinova- Hyderabad has achieved the ISO 9002 Certification. With this the Company was the first to obtain ISO 9002 certification in the field of medical diagnostics. The company has opened a medium sized Centre at Pimpri (Pune) as a part of its expansion plan. During 1998-99, The Company installed a Magnetic Resonance Imaging Unit (MRI) and the latest model of Auto Analyser Hitachi 902 at the Hyderabad Unit and a Color Doppler SONOS 2500 supplied by M/s Hewlett Packard has been installed at Kolkata Centre. A new CT scan machines was installed at Pune and Kolkata and a Cardiac equipment at Bangalore was also installed. A new and innonvative health schemes has to be flagged off to increase the revenues for the company. A new Cell Counter Machine for Haematology Department was installed in 2005; new Auto Analyser for Biochemistry Department was installed during 2006 at Kolkata centre; new Ultrasound Machine got installed in 2007 at Kolkata centre. In 2008, it installed new Auto Analyzer, Cell Counter and Semi Auto Analyzer machines at Pune and Hyderabad Centres. Equipments like Ultrasound, System, Digital Color Doppler and X Ray were acquired in 2009. Further, equipments such as Computed Radiography System and Semi Auto Analyzers got launched to upgrade the centres in 2010. Colour Droppler, Ultra Sound and Stress Test Machines were acquired in 2011. The Centres got upgraded by acquiring new CT Machine, Digital X-ray & Ultrasound Scanners in 2012. During the year 2014, Bangalore Unit of the Company was sold/transferred as-a-going-concern, on slump sale basis together with all its assets and liabilities, to M/s. Mallya Hospital (Purchaser) for a total consideration of Rs.715 lakhs, through which the transaction got completed and the sale became effective from January 31, 2014. Post sale of the Bangalore unit, the Company's retained business include the diagnostic service centres at Hyderabad, Pune, Kolkata and a mini centre at Bansdroni (Kolkata). Similarly, in 2014, M/s. Vijaya Diagnostic Centre Private Limited acquired 24.54% shares of the Company equivalent to 29.01% (29.16% of Voting Capital of MDSL) shareholding from the erstwhile Promoter M/s. Standard Medical & Pharmaceuticals Limited and made open offer for additional 26% of the Equity Shares. Consequently, M/s. Vijaya Diagnostic Centre Private Limited after completion of the open offer and acquisition of shares acquired the Management Control and became the Promoter of the Company.

Managing Director

Sunil Chandra Kondapally

Founded

1993

NSE Symbol

Medinova Diagnostic Services Ltd Management

NameDesignation
Sura Surendranath ReddyChairman & Non Executive Dir.
Sunil Chandra KondapallyManaging Director
K V Ravindra ReddyIndependent Director
P Kamalakar RaoIndependent Director
B. Vishnu Priya ReddyNon Executive Director

Medinova Diagnostic Services Ltd News

Medinova Diagnostic Services consolidated net profit declines 22.08% in the March 2024 quarter
Sales decline 9.45% to Rs 2.49 crore
Medinova Diagnostic Services to table results
On 26 April 2024
Medinova Diagnostic Services consolidated net profit rises 73.91% in the December 2023 quarter
Sales rise 7.66% to Rs 2.39 crore
Medinova Diagnostic Services to table results
On 31 January 2024
Medinova Diagnostic Services consolidated net profit rises 83.33% in the September 2023 quarter
Sales rise 12.11% to Rs 2.87 crore
Medinova Diagnostic Services to discuss results
On 2 November 2023
Medinova Diagnostic Services to convene AGM
On 18 September 2023
Medinova Diagnostic Services consolidated net profit rises 10.00% in the June 2023 quarter
Sales decline 1.63% to Rs 2.42 crore
Medinova Diagnostic Services to hold board meeting
On 28 July 2023
Medinova Diagnostic Services consolidated net profit rises 120.00% in the March 2023 quarter
Sales rise 1.85% to Rs 2.75 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
APOLLOHOSP₹ 83,506 Cr
₹ 5,834.10
(0.45 %)
83.62
MAXHEALTH₹ 77,286 Cr
₹ 810.00
(1.86 %)
135.24
MEDANTA₹ 37,490 Cr
₹ 1,414.60
(1.31 %)
107.24
FORTIS₹ 34,097 Cr
₹ 441.15
(-2.32 %)
447.18
NH₹ 25,403 Cr
₹ 1,261.70
(1.50 %)
70.87

Medinova Diagnostic Services Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Medinova Diagnostic Services Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Medinova Diagnostic Services Ltd's share price is ₹37.89 as of May 10, 2024

Medinova Diagnostic Services Ltd's P/E ratio is 19.13 times as of May 10, 2024.

Medinova Diagnostic Services Ltd's most recent financial reports indicate a price-to-book ratio of 0.00, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Medinova Diagnostic Services Ltd's market is 38 Cr as on May 10, 2024.

The current financial records of Medinova Diagnostic Services Ltd show a -63.97% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Medinova Diagnostic Services Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Medinova Diagnostic Services Ltd's 52-week high and low as of May 10, 2024 are ₹40.3 and ₹36.54 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Medinova Diagnostic Services Ltd stands at 62.14%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.